In Vitro antibiofilm activity of Salvadora persica hexane extract against selected multidrug-resistant gram-negative pathogens associated with ventilator-associated pneumonia

Clicks: 14
ID: 333814
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #212 of 220 articles by views in Journal of applied microbiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 220 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Aims Biofilm formation by multidrug-resistant (MDR) Gram-negative pathogens on endotracheal tubes is a major challenge in ventilator-associated pneumonia (VAP), necessitating novel antibiofilm agents. This study evaluated the activity of Salvadora persica hexane extract (SPHE) against clinical MDR isolates of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii relevant to VAP. Methods and Results Biofilm-forming capacity was assessed using crystal violet (CV) assays. SPHE was evaluated at sub-inhibitory and MIC concentrations to assess biofilm inhibition and the reduction of preformed biofilm. Structural changes were analysed via scanning electron microscopy (SEM) with quantitative image analysis. Expression of adhesins FimH (K. pneumoniae) and OmpA (A. baumannii) was assessed by Western blot, while cytocompatibility was tested in WRL-68 hepatocytes and dental pulp stem cells (DPSCs) via MTT assays. SPHE demonstrated stage-dependent activity. At sub-inhibitory concentrations, early biofilm formation was inhibited by 88% in P. aeruginosa and 74% in K. pneumoniae. For mature biofilms, the greatest reduction (78% biomass) occurred in A. baumannii. SEM revealed significant architectural disruption, with surface coverage reduced by up to 56% (p = 0.002). Cell viability remained > 90% in both cell lines at all tested concentrations. Conclusions SPHE exhibits species- and developmental-stage-dependent antibiofilm activity against tested MDR Gram-negative pathogens associated with VAP and induces substantial disruption of biofilm architecture. Together with preliminary cytocompatibility findings within the tested concentration range, these results support further investigation of SPHE as a potential antibiofilm candidate to limit biofilm-associated colonisation in mechanically ventilated patients.
Reference Key
openalex_W7223450035 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Journal of applied microbiology
Year 2026
DOI
10.1093/jambio/lxag255
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.